WSFS
XERS icon

Wilmington Savings Fund Society’s Xeris Biopharma Holdings XERS Stock Holding History

Wilmington Savings Fund Society’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40
Closed -$187 – 2081
2025
Q2 		$187 Hold
40
– – ﹤0.01% 2021
2025
Q1 		$220 Hold
40
– – ﹤0.01% 2042
2024
Q4 		$136 Hold
40
– – ﹤0.01% 2077
2024
Q3 		$114 Buy
+40
New +$103 ﹤0.01% 2060

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Wilmington Savings Fund Society's XERS Position: Q3 2025 in Review

Wilmington Savings Fund Society sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 40 shares — an estimated $187 sold.

Wilmington Savings Fund Society first reported a position in XERS in Q3 2024 and held it in 4 quarters. The position peaked at $220 in Q1 2025. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

  • Wilmington Savings Fund Society reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 40 Xeris Biopharma Holdings shares in Q3 2025, an estimated $187.
  • Wilmington Savings Fund Society first reported a position in Xeris Biopharma Holdings in Q3 2024 and held it in 4 quarters.
  • Wilmington Savings Fund Society's Xeris Biopharma Holdings position peaked at $220 in Q1 2025.
  • 230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q3 2025, filed 28 Oct 2025.